These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4137047)

  • 1. Lymphocytes sensitised to basic encephalitogen in patients with multiple sclerosis unresponsive to steroid therapy.
    Webb C; Teitelbaum D; Abramsky O; Arnon R; Sela M
    Lancet; 1974 Jul; 2(7872):66-9. PubMed ID: 4137047
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Basic encephalitogen and unresponsive multiple sclerosis.
    Horan AH
    Lancet; 1974 Oct; 2(7886):962. PubMed ID: 4138271
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases.
    Caspary EA; Field EJ
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):701-3. PubMed ID: 4135820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelin basic protein stimulation index of CD 2 cells in the course of steroid treatment].
    Wender M; Sniatała-Kamasa M; Wójcicka M; Tokarz-Kupczyk E; Losy J
    Neurol Neurochir Pol; 1999; 33(4):765-70. PubMed ID: 10612091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular response to basic protein and T suppressor cells in multiple sclerosis.
    Wicher V; Holub R
    Immunol Commun; 1982; 11(6):495-507. PubMed ID: 6188680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin basic protein-stimulated rosette-forming T cells in multiple sclerosis.
    Hashim GA; Lee DH; Pierce JC; Braun CW; Fitzpatrick
    Neurochem Res; 1978 Feb; 3(1):37-48. PubMed ID: 79987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy in neurological diseases.
    Cendrowski W; Riekkinen PJ; Rinne UK
    Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis-lymphocyte transformation with multiple sclerosis and normal brain myelin basic protein and subcellular fractions.
    Hughes RA; Gray IA; Gregson NA; Metcalfe RA
    Acta Neurol Scand; 1982 Mar; 65(3):161-73. PubMed ID: 6177188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects.
    Hughes RA; Gray IA; Clifford-Jones R; Stern MA
    Acta Neurol Scand; 1979 Aug; 60(2):65-76. PubMed ID: 91302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis.
    Lisak RP; Behan PO; Zweiman B; Shetty T
    Neurology; 1974 Jun; 24(6):560-4. PubMed ID: 4133960
    [No Abstract]   [Full Text] [Related]  

  • 11. Schemes to eradicate the multiple sclerosis central nervous system immune reaction.
    Tourtellotte WW; Murthy K; Brandes D; Sajben N; Ma B; Comiso P; Potvin A; Costanza A; Korelitz J
    Neurology; 1976 Jun; 26(6 PT 2):59-61. PubMed ID: 179031
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte sensitization to thymus and lymph node antigen in multiple sclerosis and other neurological diseases.
    Field EJ; Caspary EA
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):604-6. PubMed ID: 4125963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-to-mega-dose synthetic corticosteroids on multiple sclerosis patients with special reference to cerebrospinal fluid antibodies to myelin basic protein.
    Warren KG; Catz I; Carroll DJ
    Clin Neuropharmacol; 1987 Oct; 10(5):397-411. PubMed ID: 2460233
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of basic encephalitogenic protein and some peptides derived from it on the migration in agarose gel of leukocytes from patients with multiple sclerosis, other neurological diseases, or carcinoma.
    Bergstrand H; Källén B; Nilsson O
    Acta Neurol Scand; 1974; 50(2):227-47. PubMed ID: 4134200
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathogenesis of multiple sclerosis: MBP and beyond.
    Meinl E; Hohlfeld R
    Clin Exp Immunol; 2002 Jun; 128(3):395-7. PubMed ID: 12067291
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes.
    Bellini T; Degani D; Matteuzzi M; Dallocchio F
    Biosci Rep; 1990 Feb; 10(1):55-9. PubMed ID: 1692750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
    Lamers KJ; Uitdehaag BM; Hommes OR; Doesburg W; Wevers RA; von Geel WJ
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1334-7. PubMed ID: 2465387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of lymphocytes from multiple sclerosis patients to murine brain extract.
    Wicher V; Olszewski W; Flanagan TD; Milgrom F
    Immunol Commun; 1980; 9(5):465-74. PubMed ID: 6159303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
    Mackay IR; Carnegie PR; Coates AS
    Clin Exp Immunol; 1973 Dec; 15(4):471-82. PubMed ID: 4130537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.